Rosuvastatin ORBITAL Germany

Study identifier:D3560L00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Effects of a twelve months ROSUVASTATIN treatment plus additional care (drug intake adherence and lifestyle enhancing initiatives ) compared to ROSUVASTATIN treatment alone on long-term disease-related costs in patients with an indication for statin treatment according to the Joint European Guidelines

Medical condition

Hypercholesterolemia

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin

Sex

All

Actual Enrollment

8000

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Feb 2002
Primary Completion Date: -
Study Completion Date: 01 Feb 2004

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2009 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria